378 related articles for article (PubMed ID: 27846309)
21. Antihypertensive persistence and drug class.
Marentette MA; Gerth WC; Billings DK; Zarnke KB
Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
[TBL] [Abstract][Full Text] [Related]
22. Association Between Angiotensin Receptor Blocker Therapy and Incidence of Epilepsy in Patients With Hypertension.
Doege C; Luedde M; Kostev K
JAMA Neurol; 2022 Dec; 79(12):1296-1302. PubMed ID: 36251288
[TBL] [Abstract][Full Text] [Related]
23. Antihypertensive drug prescribing and persistence among new elderly users: implications for persistence improvement interventions.
Tu K; Anderson LN; Butt DA; Quan H; Hemmelgarn BR; Campbell NR; McAlister FA;
Can J Cardiol; 2014 Jun; 30(6):647-52. PubMed ID: 24882536
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials.
Shahin Y; Khan JA; Samuel N; Chetter I
Atherosclerosis; 2011 May; 216(1):7-16. PubMed ID: 21411098
[TBL] [Abstract][Full Text] [Related]
25. Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders.
Boal AH; Smith DJ; McCallum L; Muir S; Touyz RM; Dominiczak AF; Padmanabhan S
Hypertension; 2016 Nov; 68(5):1132-1138. PubMed ID: 27733585
[TBL] [Abstract][Full Text] [Related]
26. Effect of Antihypertensive Drugs on Uric Acid Metabolism in Patients with Hypertension: Cross-Sectional Cohort Study.
Ueno S; Hamada T; Taniguchi S; Ohtani N; Miyazaki S; Mizuta E; Ohtahara A; Ogino K; Yoshida A; Kuwabara M; Yoshida K; Ninomiya H; Kotake H; Taufiq F; Yamamoto K; Hisatome I
Drug Res (Stuttg); 2016 Dec; 66(12):628-632. PubMed ID: 27643410
[No Abstract] [Full Text] [Related]
27. Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: Evidence from observational studies.
Zhao Y; Wang Q; Zhao X; Meng H; Yu J
Clin Exp Hypertens; 2018; 40(1):22-27. PubMed ID: 29115847
[TBL] [Abstract][Full Text] [Related]
28. Selecting antihypertensive medication in patients with essential hypertension in Malaysia.
Ong HT; Rozina G
Med J Malaysia; 2009 Mar; 64(1):3-11. PubMed ID: 19852313
[No Abstract] [Full Text] [Related]
29. Comparing Outcomes Between Thiazide Diuretics and Other First-line Antihypertensive Drugs in Long-term Nursing Home Residents.
Boockvar KS; Song W; Lee S; Intrator O
Clin Ther; 2020 Apr; 42(4):583-591. PubMed ID: 32229030
[TBL] [Abstract][Full Text] [Related]
30. Comparative effects of antihypertensive drugs on stroke outcome in China.
Heeley EL; Wei JW; Wang JG; Arima H; Huang Y; Wong LK; Anderson CS;
Int J Stroke; 2014 Oct; 9 Suppl A100():113-8. PubMed ID: 25042450
[TBL] [Abstract][Full Text] [Related]
31. [Pharmacological basis of antihypertensive drug therapy].
Kolck UW; Zaugg CE; Erne P
Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
[TBL] [Abstract][Full Text] [Related]
32. Renin-Angiotensin System Inhibitors vs Other Antihypertensives in Hypertensive Blacks: A Meta-Analysis.
Palla M; Ando T; Androulakis E; Telila T; Briasoulis A
J Clin Hypertens (Greenwich); 2017 Apr; 19(4):344-350. PubMed ID: 27378313
[TBL] [Abstract][Full Text] [Related]
33. Antihypertensive drug treatment changes in the general population: the CoLaus study.
Christe V; Waeber G; Vollenweider P; Marques-Vidal P
BMC Pharmacol Toxicol; 2014 Mar; 15():20. PubMed ID: 24685255
[TBL] [Abstract][Full Text] [Related]
34. Antihypertensive agents and the risk of breast cancer in women aged 55 years and older: a nested case-control study.
Chang CH; Chiang CH; Yen CJ; Wu LC; Lin JW; Lai MS
J Hypertens; 2016 Mar; 34(3):558-66; discussion 566. PubMed ID: 26818924
[TBL] [Abstract][Full Text] [Related]
35. Analysis of prescription status of antihypertensive drugs in Chinese patients with hypertension based on real-world study.
Yang R; Tang J; Kuang M; Liu H
Ann Med; 2023 Dec; 55(1):276-284. PubMed ID: 36594446
[TBL] [Abstract][Full Text] [Related]
36. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
37. Development and trends in the drug treatment of essential hypertension.
van Zwieten PA
J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322
[TBL] [Abstract][Full Text] [Related]
38. Plasma renin activity (PRA) levels and antihypertensive drug use in a large healthcare system.
Sim JJ; Bhandari SK; Shi J; Kalantar-Zadeh K; Rasgon SA; Sealey JE; Laragh JH
Am J Hypertens; 2012 Mar; 25(3):379-88. PubMed ID: 22158065
[TBL] [Abstract][Full Text] [Related]
39. Intraclass differences among antihypertensive drugs.
Feldman RD; Hussain Y; Kuyper LM; McAlister FA; Padwal RS; Tobe SW
Annu Rev Pharmacol Toxicol; 2015; 55():333-52. PubMed ID: 25251994
[TBL] [Abstract][Full Text] [Related]
40. [Clinical trials on protective efficacy of antihypertensive agents for organ damage due to diabetes mellitus complicated with hypertension].
Higashiura K
Nihon Rinsho; 2004 Mar; 62 Suppl 3():623-7. PubMed ID: 15171446
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
